Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer.
about
Integrated Palliative Care and Oncologic Care in Non-Small-Cell Lung CancerLower Pectoralis Muscle Area Is Associated with a Worse Overall Survival in Non-Small Cell Lung CancerPrognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients.Prognostic factors for long term survival in patients with advanced non-small cell lung cancer.Sarcopenia and chemotherapy-mediated toxicityVariation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients.Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia.The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature.Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.Impact of chemotherapy on symptom profile, oxidant-antioxidant balance and nutritional status in non-small cell Lung Cancer.Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer.Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact.Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study.Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non-small cell lung cancer.An analysis of the types of recently published research in the field of cachexia.Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer.Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy.Loss of Muscle Mass is a Novel Predictor of Postoperative Early Recurrence in N2-Positive Non-Small-Cell Lung Cancer.ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia
P2860
Q26749199-16DF199F-133D-47D6-B6D9-3A59DEEC35A1Q28394473-52F8D6D4-CED0-47E8-A528-BFB233C6E917Q36255549-48F4412C-0D95-4A40-B3B8-7B0F1B2F8750Q36924926-820B497D-CC5E-4E1B-A292-07EA60A650DEQ37572738-A523C902-2A66-4AB9-BBA8-EB91B4BA1334Q38599598-C7A53533-60D8-4FBA-802D-5679DDD7F4DAQ38789158-276C3EEA-2E39-4DF5-AD3A-0D60D6B37452Q38842194-1715FE49-7D01-4693-A895-68AA3B9FC0E5Q39728443-8CC224EE-D3E0-4396-AF75-EB97C09CE0DCQ40979315-1A1580E2-EC44-4CE7-AFB1-837610208566Q41541734-08BB536A-840A-4A23-9D5C-1888A7AEAF1CQ42793406-4F0AE6E9-D579-443B-8FD4-709F17F0374CQ47137154-85CEEA2E-4858-41EE-BBF1-83B58E7FDB29Q47356300-EF92DD0D-85AD-4C41-B272-EC22548DC2A0Q47418565-BADD1BA6-3C17-4393-BBFB-805BBBC1AB4DQ47568983-AA91275D-1A4C-4292-B094-F52BBEE484C4Q47579713-710D5EBB-3B4A-425B-A3A0-37D297029C64Q47801764-E74C6A20-EF0E-4444-81E1-40BA8CF2193DQ49831684-EE612A2D-9A88-4785-ABFE-F46F04BD17C5Q50673188-8FA89AB7-6670-49E8-B9F1-608C548B0B9AQ59136484-831ABDC6-821B-45E5-8D13-8C9EC439A609
P2860
Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Prognostic impact of cancer ca ...... ed non-small cell lung cancer.
@en
Prognostic impact of cancer ca ...... ed non-small cell lung cancer.
@nl
type
label
Prognostic impact of cancer ca ...... ed non-small cell lung cancer.
@en
Prognostic impact of cancer ca ...... ed non-small cell lung cancer.
@nl
prefLabel
Prognostic impact of cancer ca ...... ed non-small cell lung cancer.
@en
Prognostic impact of cancer ca ...... ed non-small cell lung cancer.
@nl
P2093
P2860
P1476
Prognostic impact of cancer ca ...... ed non-small cell lung cancer.
@en
P2093
Haruyasu Murakami
Hiroaki Akamatsu
Hirotsugu Kenmotsu
Hisao Imai
Kazushige Wakuda
Keita Mori
Kyoichi Kaira
Madoka Kimura
Masahiro Endo
P2860
P2888
P304
P356
10.1007/S00520-014-2534-3
P577
2014-11-29T00:00:00Z